Seeking AlphaMon, 08 Jun 2026 16:58:33 GMTSpyre Therapeutics, Inc. (SYRE) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSYRE-12.78%
Zacks Investment ResearchThu, 04 Jun 2026 16:01:20 GMTSYRE Completes Enrollment in SKYWAY Basket Study on SPY072, Stock UpSYRE-12.78%
Zacks Investment ResearchThu, 23 Apr 2026 17:36:24 GMTSYRE Stock Jumps More Than 70% in a Month: What Is Driving This Rally?SYRE-12.78%
Seeking AlphaTue, 14 Apr 2026 11:45:06 GMTSpyre Therapeutics: Strong SPY001 Data Set Up A Catalyst-Rich 2026SYRE-12.78%
Seeking AlphaMon, 13 Apr 2026 19:21:47 GMTSpyre Therapeutics, Inc. (SYRE) Discusses SPY001 Part A Induction Topline Results From SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis TranscriptSYRE-12.78%
BenzingaMon, 13 Apr 2026 17:29:55 GMTSpyre Therapeutics Breaks Higher On Positive Data From Ulcerative Colitis DrugSYRE-12.78%
The Motley FoolWed, 08 Apr 2026 10:58:09 GMTSpyre CEO Sells $740K in Stock After 300% Surge as Key Q3 Data NearsSYRE-12.78%
